Marshall Wace, LLP Nautilus Biotechnology, Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.64 - $4.84 $30,360 - $55,660	11,500 New	11,500 $30,000
Q1 2022 May 16, 2022	SELL	$3.5 - $5.3 $131,995 - $199,878	-37,713 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.45 - $6.21 $572,327 - $798,686	-128,613 Reduced 77.33%	37,713 $195,000
Q3 2021 Nov 15, 2021	BUY	$6.14 - $10.1 $608,645 - $1 Million	99,128 Added 147.52%	166,326 $1.02 Million
Q2 2021 Aug 13, 2021	BUY	$9.04 - $14.19 $607,469 - $953,539	67,198 New	67,198 $679,000

64.3M

1.9K

100

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $297M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.